CorMedix Depreciation & Amortization 2011-2025 | CRMD

Annual Depreciation & Amortization CorMedix

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
70.8 K	84.6 K	61.9 K	128 K	73.3 K	74.2 K	36.9 K	25.6 K	15.1 K	15.1 K	5.16 K	7.02 K	12.2 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128 K	5.16 K	46.9 K

Quarterly Depreciation & Amortization CorMedix

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.6 M	-	110 K	-	-	-	21.8 K	-	-	-	16.9 K	-	62.1 K	40.8 K	20.3 K	-	41.8 K	24.3 K	12 K	-	47.3 K	37.1 K	17.7 K	-	56.6 K	40.5 K	20.1 K	-	56.8 K	38.7 K	19.4 K	-	26.7 K	17.7 K	8.77 K	-	16.9 K	8.37 K	4.07 K	-	11.1 K	7.12 K	3.16 K	-	11.5 K	1.11 K	2.45 K	-	1.63 K	1.09 K	543	-	5.27 K	3.51 K	1.76 K	-	9.29 K	6.16 K	3.04 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.6 M	543	111 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	1.4 M	$ 4.79	2.35 %	$ 795 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Aclaris Therapeutics ACRS	807 K	$ 3.04	4.83 %	$ 235 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptevo Therapeutics APVO	352 K	$ 0.93	-8.81 %	$ 257 K	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
BioVie BIVI	229 K	$ 1.27	-3.05 %	$ 1.88 M	USA
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Catalyst Biosciences CBIO	1.07 M	$ 12.37	2.06 %	$ 814 M	USA
Cerevel Therapeutics Holdings CERE	5.63 M	-	-	$ 7.29 B	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Celldex Therapeutics CLDX	3.18 M	$ 26.83	0.94 %	$ 1.73 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
Celsion Corporation CLSN	240 K	-	-6.63 %	$ 13.9 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 26.81	1.36 %	$ 1.3 B	USA
Corcept Therapeutics Incorporated CORT	795 K	$ 83.59	1.95 %	$ 8.63 B	USA
Anika Therapeutics ANIK	6.43 M	$ 9.48	0.96 %	$ 139 M	USA
Cortexyme CRTX	322 K	-	-1.05 %	$ 67.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 0.18	-25.03 %	$ 392 M	Israel
CTI BioPharma Corp. CTIC	1.95 M	-	-	$ 1.2 B	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Axon Enterprise AXON	48.4 M	$ 591.15	0.02 %	$ 44.8 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.53	-0.39 %	$ 15.9 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	41 K	-	-5.38 %	$ 6.06 M	USA